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RESEARCH ARTICLE
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Obesity and infertility are associated with poorer sexual function. We have previously shown
that a lifestyle intervention in women with obesity and infertility reduced weight and improved
cardiometabolic health and quality of life, which may positively affect sexual function. We
now report on sexual function 5 years after randomization.
Methods and findings
In total 577 women, between 18–39 years of age, with infertility and a BMI�29 kg/m2 were
randomized to a six-month lifestyle intervention targeting physical activity, diet and behavior
modification or prompt infertility care as usual. Intercourse frequency and sexual function
were assessed with the McCoy Female Sexuality Questionnaire (MFSQ), 5.4±0.8 years
after randomization. 550 women could be approached for the follow-up study, of whom 84
women in the intervention and 93 in the control group completed the MFSQ. Results were
adjusted for duration of infertility, polycystic ovary syndrome and whether women were
attempting to conceive. The intervention group more often reported having had intercourse
in the past 4 weeks compared to the control group (aOR: 2.3 95% CI 0.96 to 5.72). Among
women reporting intercourse in the past 4 weeks, the intervention group (n = 75) had inter-
course more frequently (6.6±5.8 vs. 4.9±4.0 times; 95% CI 0.10 to 3.40) and had higher
scores for vaginal lubrication (16.5±3.0 vs. 15.4±3.5; 95% CI 0.15 to 2.32) and total ‘sexual
function’ score (96.5±14.2 vs. 91.4±12.8; 95% CI 0.84 to 9.35) compared to the control
group (n = 72). Sexual interest, satisfaction, orgasm and sex partner scores did not differ
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statistically between the groups. The intervention effect on sexual function was for 21%
mediated by the change in moderate to vigorous physical activity.
Conclusion
A six-month lifestyle intervention in women with obesity and infertility led to more frequent
intercourse, better vaginal lubrication and overall sexual function 5 years after the interven-
tion. (Trial Registration: NTR1530).
Introduction
Sexual function plays an important role in the quality of life of adults and is determined by
both biological and psychosocial factors [1, 2]. The multi-dimensional nature of sexual func-
tion and the diversity in assessment methods make it difficult to estimate the prevalence of
female sexual dysfunction, but estimates are up to 40% worldwide [3–5].
Obesity and sexual function are associated through various mental and physical pathways
[6, 7]. In women, obesity leads to decreased fecundability and increases the demand for assis-
ted reproductive techniques [8–10]. Infertile couples undergoing infertility treatment report a
poorer sexual function suggesting a causal relationship between infertility and sexual function,
however a reciprocal or bidirectional association has also been suggested [11–14]. Apart from
this effect on reproduction, obesity increases the risks of cardiometabolic diseases that are also
associated with lower sexual function, like type two diabetes, dyslipidemia and hypertension
[15, 16]. Endothelial function and genital blood flow seem to form an important link between
cardiometabolic health status and sexual function, although evidence on the cause-effect rela-
tionship is scarce [17–21]. In addition, there is conflicting evidence on whether metabolic syn-
drome increases the risk of sexual dysfunction [22, 23]. Anxiety and depression are more
prevalent in the obese population, and are directly and indirectly linked to sexual function [24,
25]. Obesity may thus be a common etiological factor for decreased sexual function, explaining
the co-occurrence of multiple conditions, including mental, metabolic, reproductive and sex-
ual problems [11, 26].
The prevalence of obesity has been increasing and affects around 48% of all women of
childbearing age in the United States [27]. Lifestyle interventions are the first step in the treat-
ment of obesity and have shown to improve several domains of physical health, mental health
and increase quality of life [28–34]. Weight-loss is associated with an increase in female sexual
function, although not all intervention studies found such an effect [35]. Studies in obese and
overweight women with and without type 2 diabetes showed better sexual function after life-
style interventions, especially in women who had been diagnosed with a sexual dysfunction
prior to the intervention [36, 37].
We have previously reported on the LIFEstyle study, a Randomized Controlled Trial (RCT)
in which women with obesity and infertility were allocated to a six month lifestyle intervention
or infertility care as usual [38]. This intervention led to weight loss, improved cardiometabolic
health by halving the odds of metabolic syndrome and improved physical quality of life [30,
39]. Due to these effects that are associated with sexual function, we hypothesized that a life-
style intervention in women with obesity and infertility would improve sexual function. The
current follow-up study of the LIFEstyle study aimed to investigate the effects of a lifestyle
intervention in women with obesity and infertility on sexual function.
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Methods
The current study is a follow-up study of the women who participated in the LIFEstyle study, a
multicenter RCT. The study was conducted according to the principles of the Declaration of
Helsinki and approved by the medical ethics committee of the University Medical Centre Gro-
ningen (UMCG) (METc code: 2008/284), as well as by the board of directors of the 22 other
participating hospitals (Dutch trial register (NTR 1530)).
LIFEstyle study
The original LIFEstyle study was conducted in 23 medical centers in the Netherlands. The pro-
tocols of the original LIFEstyle study and the current follow-up study (WOMB project) have
been published previously [38, 40]. From June 2009 until June 2012, 577 women between 18–
39 years of age with infertility and a Body Mass Index (BMI)�29 kg/m2 were randomly allo-
cated (1:1) to a lifestyle intervention or infertility care as usual. Infertility was defined as
chronic anovulation [41] or unsuccessful conception for at least 12 months [42]. Women with
severe endometriosis, premature ovarian insufficiency, endocrinopathy (e.g. diabetes type I,
Cushing’s syndrome), and untreated pre-conception hypertension, or hypertension-related
complications in a previous pregnancy were not eligible, as were women treated with donor
sperm. Randomization was performed with an online program at the Academic Medical Cen-
tre in Amsterdam, stratified for trial center and ovulatory status.
Lifestyle intervention
Women allocated to the intervention group received a six-month structured lifestyle interven-
tion, prior to receiving infertility treatment. The lifestyle intervention consisted of six face-to-
face consultations of approximately 30 minutes at the outpatient clinics and four consultations
by telephone and/or e-mail with trained research nurses. The goal of the lifestyle intervention
was a 5–10% weight reduction, or a reduction in BMI below 29 kg/m2 within the intervention
period. Women who reached this goal could stop with the lifestyle intervention program and
proceed with infertility treatment. The intervention was discontinued if pregnancy occurred,
but women could re-enter the intervention in case of a miscarriage.
The intervention was based on recommendations of the National Institute of Health [43],
and consisted of a dietary, physical activity and a behavioral modification component. Women
were advised to reduce their daily caloric intake by 600 kcal, but not below 1200 kcal/day. An
online food diary was used to provide feedback on their diet. Women were recommended to
be more physical active and to increase their daily step count to a minimum of 10,000 steps per
day, supported by a pedometer that was worn daily. In addition, women had to be moderately
physically active two to three times a week for a minimum of 30 minutes. Individual motiva-
tional counselling was used to set individual goals and create awareness of lifestyle factors pre-
disposing to obesity [44]. Women were advised to adhere to their healthier lifestyle, also after
finishing the intervention.
Control strategy
Women in the control group were treated according to the Dutch infertility guidelines, irre-
spective of their BMI, and were given information about the negative effects of obesity on fer-
tility, as part of the usual care in the Netherlands [42].
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Study procedures
All women who participated in the LIFEstyle study were eligible for the current follow-up
study, five years after randomization. All women for whom valid contact information was
available were sent an invitation letter in which they received information about the follow-up
study. Women were contacted by telephone if they did not respond to the letter. All partici-
pants provided written informed consent. Participants could fill out a paper or online version
of the questionnaires at home, without the presence of a researcher.
Outcome measures
Women filled out questionnaires concerning demographics, current lifestyle, reproductive
health, quality of life (36-Item Short Form Survey), and anthropometrics [45]. The amount of
moderate to vigorous physical activity (MVPA) in minutes per week was assessed with the vali-
dated Short QUestionnaire to ASsess Health-enhancing physical activity (SQUASH), which
collects information about commuting activities, leisure time activities, household activities,
activities at work and school, using three main questions: days per week, average time per day/
week, and intensity [46].
The main outcomes of this paper were assessed using the Dutch version of the validated
McCoy Female Sexuality Questionnaire (MFSQ) [47]. The MFSQ has a good test-retest reli-
ability (r = 0.71–0.95) and discriminating capacity between women with and without sexual
dysfunction. [48] In this 19-item questionnaire, 18 items are scored on a 7-point Likert scale.
The remaining item asks about frequency of intercourse in the past 4 weeks. The questionnaire
investigates five dimensions of sexual health: sexual interest; satisfaction; vaginal lubrication;
orgasm and sex partner. Intercourse frequency, as part of the sexual satisfaction domain, is
converted into a 7-point scale on a percentage-wise basis, in which the lowest frequency is con-
verted to 1 point and the highest to 7 points. To calculate domain scores, ‘non applicable’
answers were replaced by the mean of at least 2 of the other items of the corresponding
domain. The total score is calculated in complete cases by the sum score of all individual items.
Only women who reported intercourse could complete all of the 19 items [47].
Statistical analyses
Comparison of baseline and follow-up characteristics was performed based on treatment
group. We assessed potential selection bias by comparing the baseline characteristics between
participants and non-participants. We analysed continuous variables using an independent
sample t-test, binary and categorical outcomes with a Pearson Chi-Square, Fisher’s exact test
or Fisher-Freeman-Halton exact test; p-values <0.05 were considered statistically significant.
Sexual activity was assessed in the complete sample of women who filled out the questionnaire.
In line with the MFSQ user manual, the frequency of intercourse, the five domains concerning
sexual function and total MFSQ score were analysed for all women who reported having had
intercourse at least once during the past four consecutive weeks [47]. We analysed the differ-
ences in outcomes between the intervention and control group by logistic and linear regres-
sion analyses. Duration of infertility at baseline, polycystic ovary syndrome (PCOS) and
attempting to conceive (yes or no) were added as covariates to the adjusted model. PCOS was
diagnosed by the Rotterdam 2003 criteria [49]. Results are presented as odds ratios for sexual
activity or mean difference in intercourse frequency, domain scores or total MFSQ score
between the intervention and control group. Confidence intervals (CI) for continuous out-
comes are reported as bias corrected and accelerated (BCa) 95% CI, based on 5000 bootstrap
samples [50]. Confidence intervals not including zero were considered statistically significant.
Post-hoc mediation analyses were performed for the total score of the MFSQ, including delta
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values between baseline and follow-up of factors attributable to the intervention: weight,
waist- and hip circumference, mental and physical quality of life and MVPA. The mediating
effects were analysed for all potential mediators separately and combined. The mediation anal-
yses were performed using model 4, with 5000 bootstrapped samples for the estimation of bias
corrected 95% CI, of the PROCESS macro (V.2.16.3) for SPSS [51]. All statistical analyses were
performed using IBM SPSS version 24.0 (Armonk, NY, USA). At the start of the original trial,
no power calculation was performed for sexual function as a long-term outcome [38].
Results
Participation
Flow of participants. During the original trial, 577 women were randomized, of which 3
women withdrew their informed consent and 10 women were lost to follow-up. Of the 564
women who completed the original trial, 14 women could not be contacted for the current fol-
low-up study, because of missing contact information or immigration out of the Netherlands.
All remaining 550 women (98%) were approached for the follow-up study, of whom 272
women in the intervention group and 278 women in the control group. A total of 106 of the
approached women (39%) in the intervention and 113 women (41%) in the control group
gave written informed consent. 31 of the women who gave informed consent did not respond
to the complete set of questionnaires, and 13 women did not fill out the MFSQ specifically,
because of personal reasons (not specified). In total, 84 of the approached women (31%) in the
intervention group and 93 women (33%) in the control group filled out the MFSQ and were
included in the analyses (Fig 1). Of the women in the intervention group, 13 women (15,5%)
did not complete the intervention program.
Participants and non-participants. The comparison of women who filled out the MFSQ
(N = 177) and women who did not (N = 397) is shown in S2 Table. Women who filled out the
MFSQ were more often Caucasian, were more often diagnosed with PCOS, but had shorter
duration of infertility and a higher score for mental quality of life at baseline than women who
did not fill out the MFSQ.
Characteristics of treatment groups. The characteristics of the women who participated
in the follow-up are reported separately for the intervention and control group in Tables 1 and
2 respectively. Women in the intervention group had a longer duration of infertility at baseline
(Table 1).
Sexual intercourse occurrence
Of the 177 women who filled out the MFSQ, 75 of the 84 women (89.3%) in the intervention
group compared to 72 of the 93 women (77.4%) in the control group reported having had
intercourse in the past four weeks, resulting in an Odds Ratio (OR) of 2.4 (95% CI 1.04–5.66;
p = 0.04). However, the OR was not statistically significant after adjusting for duration of infer-
tility at baseline, PCOS and whether women were attempting to conceive (aOR: 2.3 95% CI
0.96–5.72; p = 0.06). (Table 2).
In the group of women who reported having had intercourse (irrespective of the treatment
group), the prevalence of PCOS (44.2% versus 26.7%; p = 0.08) as well as the percentage of
women attempting to conceive (24.5% versus 6.7% p = 0.03) was higher in comparison to
women who reported not to have had intercourse. Furthermore, women who reported not to
have had intercourse had a lower frequency of intercourse at baseline compared to women
who had intercourse at follow-up (median 2.0 (IQR 1.0–3.0) versus 3.0 (2.0–3.0) per week;
p = 0.03) (S3 Table).
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Intercourse frequency and sexual function
Baseline- and follow-up characteristics of women reporting intercourse. The between
group comparison of characteristics of women who reported having had intercourse in the last
four weeks, at baseline and follow-up is reported in S4 Table. Women in the intervention
group had a longer duration of infertility at baseline (20.0 (IQR 14.0–40.0) versus 17.0 (12.0–
23.8) months; p = 0.04).
Fig 1. Flowchart of participants. Abbreviations: MFSQ, McCoy Female Sexuality Questionnaire.
https://doi.org/10.1371/journal.pone.0205934.g001
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Intervention effect on intercourse frequency and sexual function. Among women
reporting intercourse, the frequency of intercourse was higher in the intervention group than
in the control group (Table 3). Women in the intervention group also had higher total MFSQ
scores and higher scores on the sexual satisfaction and vaginal lubrication domains (Table 3).
After adjusting for duration of infertility at randomization, PCOS and whether women were
Table 1. Baseline characteristics of the participants.
Variables n Intervention group n Control group P-value a
Age, years–mean (SD) 84 30.2 (4.1) 93 29.7 (4.3) 0.40
Weight, kg–mean (SD) 84 104.8 (12.8) 93 103.6 (11.9) 0.52
Waist circumference, cm mean–(SD) 80 107.6 (9.6) 93 108.7 (9.4) 0.42
Hip circumference, cm mean–(SD) 82 124.7 (8.7) 93 125.1 (8.4) 0.76
Caucasian–no. (%) 84 79 (94.0) 93 90 (96.8) 0.48
Education–no. (%) 81 91 0.66
Primary school, age 4–12 year 3 (3.7) 1 (1.1)
Secondary education 15 (18.5) 20 (22.0)
Intermediate vocational education 44 (54.3) 51 (56.0)
Advanced vocational education or university 19 (23.5) 19 (20.9)
Current smoker–no. (%) 83 20 (24.1) 92 17 (18.5) 0.36
Nulliparous–no. (%) 84 65 (77.4) 93 68 (73.1) 0.51
Duration of infertility–median (IQR) 84 20.5 (14.0–37.0) 93 17.0 (12.0–24.5) 0.04
Polycystic Ovary Syndrome b—no. (%) 84 31 (36.9) 93 42 (45.2) 0.27
Physical Quality of Life–median (IQR) 68 53.0 (47.6–55.4) 83 51.3 (45.6–54.4) 0.12
Mental Quality of Life–median (IQR) 68 53.8 (50.1–57.1) 83 53.8 (48.7–56.2) 0.42
Weekly intercourse frequency, median (IQR) 65 3.0 (2.0–3.0) 81 2.0 (2.0–3.0) 0.85
a P-values of continuous outcomes based on student t-test or Mann-Whitney-U test. P-values of dichotomous and categorical outcomes are based on the Pearson Chi-
Square test, the Fisher’s exact test or Fisher-Freeman-Halton exact test.
b Diagnosed by Rotterdam 2003 criteria [49].
Abbreviations: n, number; SD, Standard Deviation.
https://doi.org/10.1371/journal.pone.0205934.t001
Table 2. Follow-up characteristics of the participants.
Variables n Intervention group n Control group P-value a
Age at follow-up, years–mean (SD) 84 35.6 (4.3) 93 35.2 (4.4) 0.49
Follow-up duration, years–mean (SD) 84 5.4 (0.9) 93 5.5 (0.7) 0.55
Weight, kg–mean (SD) 84 99.6 (15.1) 93 99.8 (16.5) 0.95
Waist circumference, cm mean–(SD) 82 107.3 (13.5) 92 108.3 (13.3) 0.62
Hip circumference, cm mean–(SD) 82 120.0 (11.4) 92 120.5 (14.4) 0.79
Long-term relationship b –no. (%) 84 75 (89.3) 93 87 (93.5) 0.42
Childlessness–no. (%) 84 18 (21.4) 93 14 (15.1) 0.27
History of miscarriage c—no. (%) 84 28 (33.3) 93 31 (33.3) 1.00
Attempting to conceive—no. (%) 84 23 (27.4) 93 15 (16.1) 0.07
a P-values of continuous outcomes based on student t-test or Mann-Whitney-U test. P-values of dichotomous and categorical outcomes are based on the Pearson Chi-
Square test or the Fisher’s exact test.
b Women who are in a relationship with the same partner as during the intervention.
c including three women with a history of extra uterine gravidity.
Abbreviations: n, number; SD, Standard Deviation.
https://doi.org/10.1371/journal.pone.0205934.t002
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attempting to conceive at time of the outcome assessment, the difference in sexual satisfaction
scores was not statistically significant. Sexual interest, orgasm and sex partner domain scores
were higher in the intervention group, but were not statistically significant (Table 3).
Mediation of the lifestyle intervention effect on sexual function. The mediation analy-
ses showed that 21% of the total intervention effect on the total MFSQ score at time of follow-
up was mediated by MVPA. No statistically significant mediating effects of change in weight,
change in waste- and hip circumference, or change in mental or physical quality of life were
observed on the intervention effect on the total MFSQ score. The combination of the media-
tors into one model explained 37% of the total intervention effect on MFSQ total score
(Table 4).
Discussion
This five-years follow-up study of an RCT shows that a lifestyle intervention in women with
obesity and infertility improves sexual function. Five years after the intervention, women in
Table 3. Comparison of intercourse frequency, MFSQ domains and total score in women reporting intercourse in the past four weeks.





Mean difference 95% CI b Mean difference 95% CI b
Intercourse frequency, number per 4 weeks–mean (SD) 6.6 (5.8) 4.9 (4.0) 1.7 0.18–3.25 1.7 0.10–3.40
Sexual interest, score–mean (SD) 28.1 (6.2) 26.3 (5.8) 1.9 -0.11–3.83 1.8 -0.07–3.67
Sexual satisfaction, score–mean (SD) 11.8 (2.6) 10.9 (2.6) 0.9 0.07–1.75 0.9 -0.03–1.73
Vaginal lubrication, score–mean (SD) 16.5 (3.0) 15.4 (3.5) 1.1 0.07–2.21 1.3 0.15–2.32
Orgasm, score–mean (SD) 20.8 (5.0) 19.5 (5.2) 1.2 -0.41–2.85 1.3 -0.27–2.81
Sex partner, score–mean (SD) 19.3 (1.9) 19.0 (2.0) 0.2 -0.39–0.86 0.2 -0.43–0.87
Total MFSQ, score–mean (SD) 96.5 (14.2) 91.4 (12.8) 5.1 0.87–9.48 5.1 0.84–9.35
a Adjusted for duration of infertility at randomization, PCOS and whether women were attempting to conceive at time of the outcome assessment.
b Bias corrected and accelerated 95% CIs based on 5000 bootstrap re-samples; CI not containing zero indicate statistical significance.
Abbreviations: n, number; SD, Standard Deviation; CI, Confidence Interval; MFSQ, McCoy Female Sexuality Questionnaire.
https://doi.org/10.1371/journal.pone.0205934.t003
Table 4. Mediation of change in measures of anthropometrics, physical activity and quality of life on MFSQ total
score.
Mediator n Indirect effect, (95% CI) a Mediation effect, % (95% CI) b
Δ Weight, kg 146 0.10 (-0.26–1.11) 1.9% (-5.1–21.6)
Δ Waist circumference, cm 140 -0.00 (-0.46–0.48) 0.0% (-9.7–10.2)
Δ Hip circumference, cm 142 0.17 (-0.21–1.33) 3.8% (-4.6–28.8)
Δ Mental quality of life score 118 -0.02 (-0.77–0.34) -0.4% (-13.8–6.0)
Δ Physical quality of life score 118 0.17 (-0.58–1.92) 3.1% (-10.3–34.1)
Δ MVPA, minutes/week c 129 1.05 (0.13–2.90) 20.7% (2.6–56.9)
Combined model d 113 1.91 (0.14–4.47) 36.9% (2.8–86.3)
a Bias corrected 95% CIs based on 5000 bootstrap re-samples. CI not containing zero indicate statistical significance.
b Mediation effect is indirect effect / total effect x 100%. CI not containing zero indicate statistical significance.
c MVPA = Moderate to vigorous physical activity in minutes per week based on SQUASH questionnaire.
d Model includes Δ weight, Δ waist circumference, Δ hip circumference, Δ mental quality of life score, Δ physical
quality of life score, Δ MVPA between baseline and follow-up as mediator variables.
Abbreviations: n, Number; BC, Bias Corrected; CI, Confidence Interval.
https://doi.org/10.1371/journal.pone.0205934.t004
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the intervention group reported a higher intercourse frequency, more vaginal lubrication and
a better overall sexual function than women in the control group. The intervention group also
scored higher on the sexual interest, satisfaction, orgasm and sex partner domains, but these
effects were not statistically significant. Our finding that the lifestyle intervention did not only
reduced weight, improved cardiovascular health and physical quality of life in the short term,
but also had lasting beneficial effects on sexual function shows that lifestyle interventions have
beneficial effects for health in a broad range of areas of health and wellbeing [39].
Randomized studies of lifestyle interventions in women with other comorbidities like type
two diabetes, that were not specifically performed in women with obesity and infertility
reported positive as well as absent effects on sexual function during or directly after a lifestyle
intervention [35, 37, 52]. A non-randomized study with a follow-up period of 2 years reported
improved sexual quality of life after a lifestyle intervention that successfully reduced weight
among obese women. Regaining body weight did not eliminate the increase in sexual quality
of life 2 years later [53]. We found similar results showing better sexual function in the inter-
vention group, despite the absence of a difference in weight at follow-up. This suggest that a
lifestyle intervention can have beneficial long-term effects on sexual health, even in the absence
of a long-term effect on weight.
The intervention effect on sexual function was partly mediated by change in physical activ-
ity. In our study, a decrease in physical activity was associated with a lower sexual function
(R = 0.23; p<0.01). Although throughout the study, physical activity decreased over time, the
intervention group reduced their physical activity less than the control group (mean delta:
-111.4 vs. -492 min/week; p = 0.03), which seems to have contributed to a better sexual func-
tion in the intervention group compared to the control group.
This study is the first to report experimental evidence of better long-term sexual function in
women with obesity and infertility after a lifestyle intervention. The validated MFSQ was part
of a more extensive survey that was filled out in private, without the presence of a researcher,
which probably has reduced the risks of performance bias and social desirability bias, increas-
ing the reliability of our results [54].
We were unable to assess the change in sexual function over time, because sexual function
was not assessed at the start of the study. Whether the difference between the intervention and
control group was based on an improved sexual function in the intervention group or
decreased sexual function in the control group could not be determined. Adjustments for
duration of infertility at randomization, PCOS, and attempting to conceive had little effect on
our results, therefore it seems unlikely that our finding of a better sexual function in the inter-
vention group was caused by these potential confounders. However, we found indications for
selective attrition by comparing the 177 participants (31.4%) with the non-participants.
Women who participated in the follow-up were more often Caucasian, were more often diag-
nosed with PCOS, but had a shorter duration of infertility and higher mental quality of life at
start of the intervention. PCOS has been associated with a poorer sexual health, whereas
shorter infertility duration and higher mental quality of life have been associated with a better
sexual function [12, 34, 55]. Due to these opposed associations with sexual function and small
absolute differences it seems unlikely that the selection in participants (S2 Table) had a sub-
stantial impact on our findings. However, the high percentage (>95%) of Caucasian women in
our sample does limit the representativeness of our findings to the Caucasian population.
Whether similar effects can be found in non-Caucasian women needs to be further
investigated.
Our study shows that even in the absence of a sustained effect on weight, a lifestyle
intervention in women with obesity and infertility leads to more frequent intercourse, better
vaginal lubrication and overall sexual function 5 years later. Thus besides short-term
Improved sexual function after lifestyle intervention in women with obesity and infertility
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improvements in cardiometabolic health and quality of life, lifestyle interventions can contrib-
ute to a better long-term sexual function in women who are at greater risk of sexual problems.
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